Medicine and Dentistry
Patient
100%
Therapeutic Procedure
29%
Inpatient
23%
Combination Therapy
21%
Surgery
16%
Skill
15%
Surgeon
12%
Heart Failure
11%
Clinical Trial
10%
Suture Material
10%
Overall Survival
10%
Non Small Cell Lung Cancer
10%
Progression Free Survival
9%
Neoplasm
9%
Analysis
8%
Cells
8%
Athletic Training
8%
Lung Cancer
8%
Development
8%
Cardiovascular System
7%
Age
7%
Assessment
6%
Blood Pressure
6%
Maturity Onset Diabetes of the Young
6%
Epidermal Growth Factor Receptor
6%
Arm
6%
Rosuvastatin
6%
Association
6%
Diseases
6%
Osimertinib
5%
Family
5%
Pediatric Surgeon
5%
Lipid
5%
Survival
5%
Chemotherapy
5%
Evaluation Study
5%
Epidermal Growth Factor Receptor
5%
Exercise
5%
Pemetrexed
5%
Paclitaxel
5%
Magnetic Resonance Imaging
5%
Female
5%
Phase II Trials
5%
Hospital
5%
Hazard Ratio
5%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
11%
Paclitaxel
11%
Non Small Cell Lung Cancer
11%
Progression Free Survival
10%
Lung Cancer
9%
Adverse Event
8%
Osimertinib
8%
Angiotensin Receptor Antagonist
7%
Carboplatin
7%
Overall Survival
7%
Toxicity
7%
Epidermal Growth Factor Receptor
6%
Warfarin
6%
Liver Cirrhosis
6%
Congestive Cardiomyopathy
6%
Chronic Thromboembolic Pulmonary Hypertension
6%
Statin (Protein)
6%
Diseases
5%
Pitavastatin
5%
Chemotherapy
5%
Deterioration
5%
Disease Exacerbation
5%
Biochemistry, Genetics and Molecular Biology
Mutation
10%
Peroxidase
6%
Clinical Trial
5%
Nested Gene
5%